Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLK1 | P53350 | 18/20 | 0.67 |
| ▸ | PLK3 | Q9H4B4 | 9/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.62 |
| ▸ | IKBKE | Q14164 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5002751 | 0.92 | PLK1 (0.71) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL4403598 | 0.91 | PLK1 (0.80) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL3151029 | 0.90 | PLK1 (0.68) | PLK1PLK3CYP3A4CYP2C9IKBKE | |
| SCHEMBL4401446 | 0.87 | PLK1 (0.84) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL3738501 | 0.86 | PLK1 (0.67) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL4403532 | 0.86 | PLK1 (0.85) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL4412008 | 0.86 | PLK1 (0.85) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL4562031 | 0.86 | PLK1 (0.85) | PLK1PLK3CYP3A4CYP2C9 | |
| SCHEMBL2980126 | 0.85 | PLK1 (0.72) | PLK1PLK3CYP3A4CYP2C9IKBKE | |
| SCHEMBL5578814 | 0.85 | PLK1 (0.72) | PLK1PLK3CYP3A4CYP2C9IKBKE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1924572-B1 | REGIOSELECTIVE PROCESS FOR PREPARING BENZIMIDAZOLE THIOPHENES | SMITHKLINE BEECHAM CORP (US) | 2009-12-30 | — | — | EP | disclosed |
| US-20080249301-A1 | Regioselective Process for Preparing Benzimidazole Thiophenes | SMITHKLINE BEECHAM CORPORATION | 2008-10-09 | — | — | US | disclosed |
| US-20080249301-A1 | Regioselective Process for Preparing Benzimidazole Thiophenes | SMITHKLINE BEECHAM CORPORATION | 2008-10-09 | — | — | US | disclosed |
| US-20080249301-A1 | Regioselective Process for Preparing Benzimidazole Thiophenes | SMITHKLINE BEECHAM CORPORATION | 2008-10-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080249301-A1 | Regioselective Process for Preparing Benzimidazole Thiophenes | CYP3A4, CYP2C19, CYP2B6 | PLK1 1718/4885PLK3 2097/4885CYP3A4 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.